Corteva, Inc. $CTVA Shares Acquired by EP Wealth Advisors LLC

EP Wealth Advisors LLC lifted its holdings in shares of Corteva, Inc. (NYSE:CTVAFree Report) by 3.2% during the 1st quarter, Holdings Channel reports. The firm owned 18,691 shares of the company’s stock after buying an additional 578 shares during the period. EP Wealth Advisors LLC’s holdings in Corteva were worth $1,176,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Cary Street Partners Financial LLC increased its stake in shares of Corteva by 20.7% during the first quarter. Cary Street Partners Financial LLC now owns 90,206 shares of the company’s stock worth $5,677,000 after buying an additional 15,448 shares during the period. Scissortail Wealth Management LLC increased its stake in shares of Corteva by 72,080.0% during the fourth quarter. Scissortail Wealth Management LLC now owns 3,609 shares of the company’s stock worth $206,000 after buying an additional 3,604 shares during the period. Allworth Financial LP increased its stake in shares of Corteva by 11.8% during the first quarter. Allworth Financial LP now owns 15,313 shares of the company’s stock worth $945,000 after buying an additional 1,614 shares during the period. Brighton Jones LLC increased its stake in shares of Corteva by 307.2% during the fourth quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock worth $888,000 after buying an additional 11,760 shares during the period. Finally, Farther Finance Advisors LLC increased its stake in shares of Corteva by 13.9% during the first quarter. Farther Finance Advisors LLC now owns 4,387 shares of the company’s stock worth $279,000 after buying an additional 536 shares during the period. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Corteva news, EVP Robert D. King sold 37,280 shares of the business’s stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $74.20, for a total value of $2,766,176.00. Following the completion of the sale, the executive vice president owned 49,262 shares in the company, valued at approximately $3,655,240.40. The trade was a 43.08% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.14% of the company’s stock.

Corteva Price Performance

Shares of NYSE CTVA opened at $72.64 on Friday. The company has a current ratio of 1.68, a quick ratio of 1.23 and a debt-to-equity ratio of 0.06. Corteva, Inc. has a twelve month low of $53.40 and a twelve month high of $77.41. The stock has a 50 day moving average of $73.39 and a two-hundred day moving average of $67.72. The stock has a market cap of $49.33 billion, a P/E ratio of 35.43, a P/E/G ratio of 1.66 and a beta of 0.78.

Corteva (NYSE:CTVAGet Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The company reported $2.20 earnings per share for the quarter, beating analysts’ consensus estimates of $1.89 by $0.31. Corteva had a return on equity of 8.68% and a net margin of 8.16%.The company had revenue of $6.46 billion during the quarter, compared to analysts’ expectations of $6.26 billion. During the same quarter in the previous year, the business earned $1.83 earnings per share. The firm’s revenue for the quarter was up 5.6% on a year-over-year basis. On average, research analysts forecast that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, September 15th. Shareholders of record on Tuesday, September 2nd will be paid a $0.18 dividend. This is an increase from Corteva’s previous quarterly dividend of $0.17. This represents a $0.72 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date is Tuesday, September 2nd. Corteva’s dividend payout ratio (DPR) is presently 35.12%.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on CTVA. Citigroup upped their target price on shares of Corteva from $75.00 to $78.00 and gave the stock a “buy” rating in a research note on Friday, May 9th. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Corteva in a report on Monday, August 11th. Morgan Stanley upped their price target on Corteva from $65.00 to $71.00 and gave the company an “overweight” rating in a report on Friday, May 9th. KeyCorp upped their price target on Corteva from $84.00 to $85.00 and gave the company an “overweight” rating in a report on Friday, August 8th. Finally, Barclays raised Corteva from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $75.00 to $84.00 in a report on Wednesday, August 13th. Thirteen analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $80.25.

View Our Latest Report on Corteva

Corteva Company Profile

(Free Report)

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.

See Also

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVAFree Report).

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.